Literature DB >> 22835209

The association between cognitive impairment and neuropsychiatric symptoms in patients with Parkinson's disease dementia.

Wei-Ju Lee1, Chia-Fen Tsai, Serge Gauthier, Shuu-Jiun Wang, Jong-Ling Fuh.   

Abstract

BACKGROUND: Neuropsychiatric symptoms (NPS) are common in patients with dementia associated with Parkinson's disease (PDD). The relationship between cognition and NPS in PDD has not been well studied.
METHODS: Patients diagnosed with PDD were assessed for cognitive function and NPS. The instruments used were the Neuropsychiatric Inventory (NPI), Mini-Mental State Examination (MMSE), and semantic verbal fluency according to the recommendation of the Movement Disorder Society Task Force.
RESULTS: We evaluated 127 PDD patients (76 males/51 females; mean age 77 ± 6.3 years). Their mean MMSE score was 17 ± 6.5 and the mean NPI score was 19 ± 20.4. The most prevalent NPI items were anxiety (57.5%), sleep problems (53.5%), and apathy (52.0%). Principal component factor analysis revealed that 12 items formed three factors, namely "mood and psychosis" (delusion, hallucination, agitation, depression, anxiety, apathy, and irritability), "vegetative" (sleep and appetite problems), and "frontal" (euphoria, disinhibition, and aberrant motor behavior). Symptoms of hallucination were significantly associated with MMSE score, even after controlling for the confounding variables.
CONCLUSION: NPS are common and diverse among patients with PDD. Three specific subgroups of NPS were identified. Hallucination was significantly correlated with cognitive impairment, and could be a predictor of cognition in PDD patients.

Entities:  

Mesh:

Year:  2012        PMID: 22835209     DOI: 10.1017/S1041610212001317

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  10 in total

Review 1.  Psychiatric issues in cognitive impairment.

Authors:  Dag Aarsland; John-Paul Taylor; Daniel Weintraub
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

2.  White matter disease contributes to apathy and disinhibition in behavioral variant frontotemporal dementia.

Authors:  John P Powers; Lauren Massimo; Corey T McMillan; Paul A Yushkevich; Hui Zhang; James C Gee; Murray Grossman
Journal:  Cogn Behav Neurol       Date:  2014-12       Impact factor: 1.600

3.  Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease.

Authors:  Nadeeka N W Dissanayaka; Elizabeth White; John D O'Sullivan; Rodney Marsh; Peter A Silburn; David A Copland; George D Mellick; Gerard J Byrne
Journal:  Mov Disord Clin Pract       Date:  2015-04-06

4.  Apathy rating scores and β-amyloidopathy in patients with Parkinson disease at risk for cognitive decline.

Authors:  Zhi Zhou; Martijn L T M Müller; Prabesh Kanel; Jason Chua; Vikas Kotagal; Daniel I Kaufer; Roger L Albin; Kirk A Frey; Nicolaas I Bohnen
Journal:  Neurology       Date:  2019-11-15       Impact factor: 9.910

Review 5.  Dementia-related psychosis and the potential role for pimavanserin.

Authors:  Jeffery L Cummings; D P Devanand; Stephen M Stahl
Journal:  CNS Spectr       Date:  2020-08-19       Impact factor: 3.790

6.  Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.

Authors:  Emilia Schwertner; Joana B Pereira; Hong Xu; Juraj Secnik; Bengt Winblad; Maria Eriksdotter; Katarina Nägga; Dorota Religa
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

7.  Visual hallucinations and inferior longitudinal fasciculus in Parkinson's disease.

Authors:  Natsuko Yuki; Akira Yoshioka; Ryo Mizuhara; Tadashi Kimura
Journal:  Brain Behav       Date:  2020-10-20       Impact factor: 2.708

8.  Development and assessment of a brief screening tool for psychosis in dementia.

Authors:  Jeffrey L Cummings; Zahinoor Ismail; Bradford C Dickerson; Clive Ballard; George Grossberg; Bradley McEvoy; Erin Foff; Alireza Atri
Journal:  Alzheimers Dement (Amst)       Date:  2021-12-07

Review 9.  Merging Clinical and Imaging Biomarkers to Tackle Parkinson's Disease.

Authors:  Marina Picillo; Paolo Barone; Maria Teresa Pellecchia
Journal:  Mov Disord Clin Pract       Date:  2017-08-21

10.  Fifty Percent Prevalence of Extracampine Hallucinations in Parkinson's Disease Patients.

Authors:  Ruth A Wood; Sarah A Hopkins; Kuven K Moodley; Dennis Chan
Journal:  Front Neurol       Date:  2015-12-21       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.